SCTbio Your Partner in Cost Effective Quality Manufacturing Services

Fifteen years of cell therapy expertise has taught us what matters most. Our network of 150 apheresis centers across EU & USA, combined with state-of-the-art manufacturing capabilities and proprietary logistics software, has successfully guided therapies from preclinical stages through Phase III.

As a long-term manufacturing partner, we will strategically guide our business partners through every step of the cell therapy manufacturing chain. We offer full services covering GMP production of Advanced Therapy Medicinal Products including genetically modified and viral vectors: manufacturing, quality control, QA/QP release, storage and logistics services and process development services to deliver the highest quality collaboration for your CDMO needs.

Don't miss our presentation by our CEO, Ludek Sojka, "Game-Changing Plasmid Strategies: Driving Efficiency in LVV Manufacturing" on April 9th at 3:40 PM (Coffeon), where we'll unveil breakthrough data on platform optimization across media, time, and temperature variables.
Lentiviral vectors are essential delivery vehicles for cell therapies, but manufacturing challenges are still impacting development timelines and costs.

Come along and learn how innovative plasmid DNA strategies can:

• improve production efficiency
• reduce costs
• accelerate patient access to these transformative therapies

Ready to discuss your specific needs?
Secure your preferred meeting time: partnering@sctbio.com

^{* Advertisement - in cooperation with SCTbio*}